(Q36673531)

15 August 2017

1 reference

title

Coagulation interventions in experimental human endotoxemia (English)

1 reference

15 August 2017

2

Bernd Jilma

1 reference

15 August 2017

Florian B Mayr

1

1 reference

15 August 2017

publication date

1 November 2006

1 reference

15 August 2017

published in

Translational Research

1 reference

15 August 2017

volume

148

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

263-271

1 reference

Bidirectional relation between inflammation and coagulation

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Clinical impact of novel anticoagulation strategies in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Response of man to endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

New insights into the biology of the acute phase response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

The cardiovascular response of normal humans to the administration of endotoxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Heparin blunts endotoxin-induced coagulation activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Procoagulant protein levels are differentially increased during human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Systemic inflammation increases shear stress-induced platelet plug formation measured by the PFA-100

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Polymorphism in the tissue factor region is associated with basal but not endotoxin-induced tissue factor-mRNA levels in leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Markers of endothelial damage in organ dysfunction and sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

In vivo protection against endotoxin by plasma high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Activation of coagulation after administration of tumor necrosis factor to normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Interleukin 6 and haemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Biological properties of interleukin 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Cell biology of tissue factor, the principal initiator of blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Initiation and regulation of tissue factor-dependent blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Tissue factor and plasminogen activator inhibitor type 2 expression in human stimulated monocytes is inhibited by heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Static and Dynamic Assessment of Biomarkers in Surgical Patients with Severe Sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Effects of drotrecogin alfa (activated) in human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Characterization of protein C receptor expression in monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Comparison of mechanisms after post-hoc analyses of the drotrecogin alfa (activated) and antithrombin III trials in severe sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

A cell-based model of hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Effects of anticoagulation on thrombopoietin release during endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: a randomized, placebo-controlled, clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

The P-selectin, tissue factor, coagulation triad

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Epinephrine exerts anticoagulant effects during human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Dobutamine does not influence inflammatory pathways during human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Relative efficacy and potency of beta-adrenoceptor agonists for generating cAMP in human lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Dobutamine antagonizes epinephrine's biochemical and cardiotonic effects: results of an in vitro model using human lymphocytes and a clinical study in patients recovering from cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Selectivity of dobutamine for adrenergic receptor subtypes: in vitro analysis by radioligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Human models of endotoxemia and recombinant human activated protein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.08.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2006.08.002

1 reference

15 August 2017

1 reference